Dr. Julie A. Goddard, MD

Dr. Goddard practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Goddard's NPI, 1700014875, was assigned on June 29, 2009. Dr. Goddard graduated from Baylor College of Medicine in 2004. Dr. Goddard holds Colorado license 48042.

Dr. Goddard's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Goddard's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Goddard is also affiliated with Denver Health Medical Center. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Goddard to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goddard practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Goddard's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Goddard's licenses on file in 3 states: Colorado, California and Ohio.

CMS data shows 427 Medicare services from Dr. Goddard across 9 procedure codes in 2024, for 180 Medicare patients. Medicare paid $54,021 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 180 Medicare patients who saw Dr. Goddard in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goddard's median patient age at 72, with 47% women.

In 2024, Dr. Goddard wrote 84 Medicare Part D claims for 36 patients. 87% of them were for generic drugs.

Dr. Goddard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goddard as offering telehealth. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Goddard, more than 66% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Goddard, published from 2013 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Squamous Cell Carcinoma of Head and Neck. Dr. Goddard has published most often in Cancer. Dr. Goddard's most frequent co-authors are Sana Dole Karam, MD, Yarah Mahmoud Haidar, MD and Jessica Dreger McDermott, MD.

Dmand AI links Dr. Goddard to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. University of Colorado, Denver sponsors the most, 2.

CMS Open Payments shows 26 general payments to Dr. Goddard from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. DePuy Synthes Sales Inc. paid the most, $915.

Dr. Goddard graduated from Baylor College of Medicine in 2004.